Impact of Statins in Outcomes of Septic Patients: A Systematic Review

References

• . Martin GS. Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes. Expert Rev Anti Infect Ther. 2012;10:701–706
   PubMed Web of Science ®Google Scholar
• . Vincent JL, Sakr Y, Sprung CL,. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34:344–353
   PubMed Web of Science ®Google Scholar
• . Heron M. Deaths: leading causes for 2008. Natl Vital Stat Rep. 2012;60:1–94
   PubMedGoogle Scholar
• . Increase in National Hospital Discharge Survey rates for septicemia—United States, 1979–1987. MMWR Morb Mortal Wkly Rep. 1990;39:31–34
   PubMedGoogle Scholar
• . Angus DC, Linde-Zwirble WT, Lidicker J,. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303–1310
   PubMed Web of Science ®Google Scholar
• . Bone RC, Balk RA, Cerra FB,; American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. Definitions for sepsis, and organ failure and guidelines for the use of innovative therapies in sepsis. 1992. Chest. 2009;36( 5 Suppl):e28
   Google Scholar
• . Australasian Resuscitation of Sepsis Evaluation (ARISE); Australian and New Zealand Intensive Care Society Adult Patient Database (ANZICS APD) Management Committee. The outcome of patients with sepsis and septic shock presenting to emergency departments in Australia and New Zealand. Crit Care Resusc. 2007;9:198–204
   PubMedGoogle Scholar
• . Levy MM, Dellinger RP, Townsend SR,. The surviving sepsis campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med. 2010;36:222–231
   PubMed Web of Science ®Google Scholar
• . Annane D, Timsit JF, Megarbane B,. Recombinant human activated protein C for adults with septic shock: a randomized controlled trial. Am J Respir Crit Care Med. 2013;187:1091–1097
   PubMedGoogle Scholar
• . Cinel I, Opal SM. Molecular biology of inflammation and sepsis: a primer. Crit Care Med. 2009;37:291–304
   PubMed Web of Science ®Google Scholar
• . Phillip Dellinger R, Parrillo JE. Mediator modulation therapy of severe sepsis and septic shock: does it work? Crit Care Med. 2004;32:282–286
   PubMedGoogle Scholar
• . Russell JA, Walley KR. Update in sepsis 2012. Am J Resp Crit Care Med. 2013;187:1303–1307
   PubMedGoogle Scholar
• . Lazar LD, Pletcher MJ, Coxson PG,. Cost effectiveness of statin therapy for primary prevention in a low-cost statin era. Circulation. 2011;124:146–153
   PubMed Web of Science ®Google Scholar
• . Frost FJ, Petersen H, Tollestrup K,. Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins. Chest. 2007;131:1006–1012
   PubMed Web of Science ®Google Scholar
• . Istvan ES, Deisenhofer J. Structural mechanism for statin inhibition of HMG-CoA reductase. Science. 2001;292:1160–1164
   PubMed Web of Science ®Google Scholar
• . Kwak B, Mulhaupt F, Myit S,. Statins as a newly recognized type of immunomodulator. Nat Med. 2000;6:1399–1402
   PubMed Web of Science ®Google Scholar
• . Terblanche M, Almog Y, Rosenson RS,. Statins and sepsis: multiple modifications at multiple levels. Lancet Infect Dis. 2007;7:358–368
   PubMed Web of Science ®Google Scholar
• . Niessner A, Steiner S, Speidl WS,. Simvastatin suppresses endotoxin-induced upregulation of toll like-receptors 4 and 2 in vivo. Atherosclerosis. 2006;189:408–413
   PubMed Web of Science ®Google Scholar
• . Shi J, Wang J, Zheng H,. Statins increase thrombomodulin expression and function in human endothelial cells by a nitric oxide-dependent mechanism and counteract tumor necrosis factor alpha induced thrombomodulin downregulation. Blood Coagul Fibrinolysis. 2003;14:575–585
   PubMedGoogle Scholar
• . McGown CC, Brown NJ, Hellewell PG,. ROCK induced inflammation of the microcirculation during endotoxemia mediated by nitric oxide synthase. Microvasc Res. 2011;81:281–288
   PubMed Web of Science ®Google Scholar
• . Catron DM, Lange Y, Borensztajn J,. Salmonella enterica serovar. Typhimurium requires nonsterol precursors of the cholesterol biosynthetic pathway for intracellular proliferation. Infect Immun. 2004;72:1036–1042
   PubMed Web of Science ®Google Scholar
• . del Real G, Jimenez-Baranda S, Mira E,. Statins inhibit HIV-1 infection by down-regulating Rho activity. J Exp Med. 2004;200:541–547
   PubMed Web of Science ®Google Scholar
• . Potena L, Frascaroli G, Grigioni F,. Hydroxymethyl-glutaryl coenzyme A reductase inhibition limits cytomegalovirus infection in human endothelial cells. Circulation. 2004;109:532–536
   PubMed Web of Science ®Google Scholar
• . Wilding EI, Brown JR, Bryant AP,. Identification, evolution, and essentiality of the mevalonate pathway for isopentenyl diphosphate biosynthesis in gram-positive cocci. J Bacteriol. 2000;182:4319–4327
   PubMed Web of Science ®Google Scholar
• . Sun HY, Singh N. Antimicrobial and immunomodulatory attributes of statins: relevance in solid-organ transplant recipients. Clin Infect Dis. 2009;48:745–755
   PubMedGoogle Scholar
• . Parks LW, Casey WM. Physiological implications of sterol biosynthesis in yeast. Annu Rev Microbiol. 1995;49:95–116
   PubMed Web of Science ®Google Scholar
• . Hackam DG, Mamdani M, Li P,. Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis. Lancet. 2006;367:413–418
   PubMed Web of Science ®Google Scholar
• . Martin CP, Talbert RL, Burgess DS,. Effectiveness of statins in reducing the rate of severe sepsis: a retrospective evaluation. Pharmacotherapy. 2007;27:20–26
   PubMedGoogle Scholar
• . Almog Y, Shefer A, Novack V,. Prior statin therapy is associated with a decreased rate of severe sepsis. Circulation. 2004;110:880–885
   PubMed Web of Science ®Google Scholar
• . Gupta R, Plantinga LC, Fink NE,. Statin use and sepsis events [corrected] in patients with chronic kidney disease. JAMA. 2007;297:1455–1464
   PubMedGoogle Scholar
• . Kruger PS, Harward ML, Jones MA,. Continuation of statin therapy in patients with presumed infection: a randomized controlled trial. Am J Respir Crit Care Med. 2011;183:774–781
   PubMedGoogle Scholar
• . Sukhija R, Bursac Z, Kakar P,. Effect of statins on the development of renal dysfunction. Am J Cardiol. 2008;101:975–979
   PubMedGoogle Scholar
• . Schouten O, Welten GM, Poldermans D. Statins and postoperative renal function. Eur J Vasc Endovasc Surg. 2010;40:616–617
   PubMedGoogle Scholar
• . Craig TR, Duffy MJ, Shyamsundar M,. A randomized clinical trial of hydroxymethylglutarylcoenzyme a reductase inhibition for acute lung injury (the HARP study). Am J Respir Crit Care Med. 2011;183:620–626
   PubMed Web of Science ®Google Scholar
• . Terblanche M, Smith TS, Adhikari NK. Statins, bugs and prophylaxis: intriguing possibilities. Crit Care. 2006;10:168
   PubMedGoogle Scholar
• . Ajrouche R, Al-Hajje A, El-Helou N,. Statins decrease mortality in Lebanese patients with sepsis: a multicenter study. Pharmacy Practice (Internet). 2013;11:102–108
   PubMedGoogle Scholar
• . Al Harbi SA, Tamim HM, Arabi YM. Association between statin therapy and outcomes in critically ill patients: a nested cohort study. BMC Clin Pharmacol. 2011;11:12
   PubMedGoogle Scholar
• . Dobesh PP, Klepser DG, McGuire TR,. Reduction in mortality associated with statin therapy in patients with severe sepsis. Pharmacotherapy. 2009;29:621–630
   PubMed Web of Science ®Google Scholar
• . Fuller BM, Gajera M, Schorr C,. The association of prior statin use in septic shock treated with early goal directed therapy. Eur J Emerg Med. 2012;19:226–230
   PubMed Web of Science ®Google Scholar
• . Goodin J, Manrique C, Dulohery M,. Effect of statins on the clinical outcomes of patients with sepsis. Anaesth Intensive Care. 2011;39:1051–1055
   PubMed Web of Science ®Google Scholar
• . Leung S, Pokharel R, Gong MN. Statins and outcomes in patients with bloodstream infection: a propensity-matched analysis. Crit Care Med. 2012;40:1064–1071
   PubMed Web of Science ®Google Scholar
• . Mekontso Dessap A, Ouanes I, Rana N,. Effects of discontinuing or continuing ongoing statin therapy in severe sepsis and septic shock: a retrospective cohort study. Crit Care. 2011;15:R171
   PubMedGoogle Scholar
• . Nseir W, Mograbi J, Abu-Elheja O,. The impact of prior long-term versus short-term statin use on the mortality of bacteraemic patients. Infect. 2012;40:41–48
   PubMed Web of Science ®Google Scholar
• . Williams JM, Greenslade JH, Chu K,. Prior statin use is not associated with improved outcome in emergency patients admitted with infection: a prospective observational study. Acad Emerg Med. 2011;18:127–134
   PubMedGoogle Scholar
• . Yende S, Milbrandt EB, Kellum JA,. Understanding the potential role of statins in pneumonia and sepsis. Crit Care Med. 2011;39:1871–1878
   PubMedGoogle Scholar
• . Kruger P, Bailey M, Bellomo R,. A multicenter randomized trial of atorvastatin therapy in intensive care patients with severe sepsis. Am J Respir Crit Care Med. 2013;187:743–750
   PubMed Web of Science ®Google Scholar
• . Novack V, Eisinger M, Frenkel A,. The effects of statin therapy on inflammatory cytokines in patients with bacterial infections: a randomized double-blind placebo controlled clinical trial. Intensive Care Med. 2009;35:1255–1260
   PubMed Web of Science ®Google Scholar
• . Patel JM, Snaith C, Thickett DR,. Randomized double-blind placebo-controlled trial of 40 mg/day of atorvastatin in reducing the severity of sepsis in ward patients (ASEPSIS trial). Crit Care. 2012;16:R231
   PubMed Web of Science ®Google Scholar
• . Papazian L, Roch A, Charles PE,. Effect of statin therapy on mortality in patients with ventilator-associated pneumonia: a randomized clinical trial. JAMA. 2013;310:1692–1700
   PubMed Web of Science ®Google Scholar
• . Liberati A, Altman DG, Tetzlaff J,. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62:1–34
   PubMedGoogle Scholar
• . Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603–605
   PubMed Web of Science ®Google Scholar
• . Hsu J, Andes DR, Knasinski V,. Statins are associated with improved outcomes of bloodstream infection in solid-organ transplant recipients. Eur J Clin Microbiol Infect Dis. 2009;28:1343–1351
   PubMed Web of Science ®Google Scholar
• . Kruger P, Fitzsimmons K, Cook D,. Statin therapy is associated with fewer deaths in patients with bacteraemia. Intensive Care Med. 2006;32:75–79
   PubMed Web of Science ®Google Scholar
• . Liappis AP, Kan VL, Rochester CG,. The effect of statins on mortality in patients with bacteremia. Clin Infect Dis. 2001;33:1352–1357
   PubMed Web of Science ®Google Scholar
• . Mortensen EM, Restrepo MI, Copeland LA,. Impact of previous statin and angiotensin II receptor blocker use on mortality in patients hospitalized with sepsis. Pharmacotherapy. 2007;27:1619–1626
   PubMed Web of Science ®Google Scholar
• . O'Neal HR, Jr., Koyama T, Koehler EA,. Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome. Crit Care Med. 2011;39:1343–1350
   PubMed Web of Science ®Google Scholar
• . Yang KC, Chien JY, Tseng WK,. Statins do not improve short-term survival in an oriental population with sepsis. Am J Emerg Med. 2007;25:494–501
   PubMed Web of Science ®Google Scholar
• . Kayani WT, Bandeali SJ, Lee VV,. Association between statins and infections after coronary artery bypass grafting. Int J Cardiol. 2013;168:117–120
   PubMed Web of Science ®Google Scholar
• . Thomsen RW, Hundborg HH, Johnsen SP,. Statin use and mortality within 180 days after bacteremia: a population-based cohort study. Crit Care Med. 2006;34:1080–1086
   PubMed Web of Science ®Google Scholar
• . Viasus D, Gudiol C, Fernandez-Sabe N,. Effect of statins on outcomes in immunosuppressed patients with bloodstream infection. Eur J Clin Microbiol Infect Dis. 2011;30:77–82
   PubMedGoogle Scholar
• . Identifier: Cg, NCT00528580. Statins for the Early Treatment of Sepsis (SETS). www.clinicaltrials.gov
   Google Scholar
• . Merx MW, Liehn EA, Graf J,. Statin treatment after onset of sepsis in a murine model improves survival. Circulation. 2005;112:117–124
   PubMed Web of Science ®Google Scholar
• . Ando H, Takamura T, Ota T, Nagai Y, Kobayashi K. Cerivastatin improves survival of mice with lipopolysaccharide-induced sepsis. J Pharmacol Exp Ther. 2000;294:1043–1046
   PubMed Web of Science ®Google Scholar
• . Chalmers JD, Singanayagam A, Murray MP,. Prior statin use is associated with improved outcomes in community acquired pneumonia. Am J Med. 2008;121:1002–1007
   PubMed Web of Science ®Google Scholar
• . Bellosta S, Paoletti R, Corsini A. Safety of statins: focus on clinical pharmacokinetics and drug interactions. Circulation. 2004;109:50–57
   Web of Science ®Google Scholar
• . Brealey DA, Singer M, Terblanche M. Potential metabolic consequences of statins in sepsis. Crit Care Med. 2011;39:1514–1520
   PubMedGoogle Scholar
• . Abd TT, Jacobson TA. Statin-induced myopathy: a review and update. Expert Opin Drug Saf. 2011;10:373–387
   PubMed Web of Science ®Google Scholar